合肥(fei)創(chuang)新(xin)(xin)醫藥(yao)技(ji)術有限公(gong)(gong)(gong)司(si)(簡稱:公(gong)(gong)(gong)司(si)、創(chuang)新(xin)(xin)醫藥(yao))2001年(nian)成立,是安(an)徽(hui)(hui)省(sheng)科技(ji)廳認定的科研(yan)(yan)單(dan)位,安(an)徽(hui)(hui)省(sheng)新(xin)(xin)型研(yan)(yan)發機構(gou)。公(gong)(gong)(gong)司(si)一(yi)(yi)直持(chi)(chi)續專注中西新(xin)(xin)藥(yao)研(yan)(yan)發、服(fu)務;2018年(nian)以來(lai),戰略布局創(chuang)新(xin)(xin)MAH持(chi)(chi)有人品(pin)種研(yan)(yan)發,搶仿市(shi)場(chang)緊缺化藥(yao)特色品(pin)種,通(tong)過挖掘療效突出(chu)的中藥(yao)經典名方和(he)同(tong)名同(tong)方,加大自主產權創(chuang)新(xin)(xin)藥(yao)的研(yan)(yan)發,發展為中西新(xin)(xin)藥(yao)研(yan)(yan)發、臨床、生產、銷售一(yi)(yi)體化商業模(mo)式。
目前,公司研發和儲備了大量自主產權(quan)的中(zhong)藥(yao)(yao)創新(xin)(xin)品種(創新(xin)(xin)1類),在我國中(zhong)藥(yao)(yao)正(zheng)在迎(ying)來(lai)大好(hao)的發展(zhan)機遇下(xia),將成為具潛(qian)力和特色的自主創新(xin)(xin)型(xing)醫藥(yao)(yao)企業,2023年實現(xian)國內(nei)外IPO。